ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastric Cancer Therapy Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-7M13854
Home | Market Reports | Health| Health Conditions| Cancer
Global Gastric Cancer Therapy Market Research Report 2023
BUY CHAPTERS

Global Gastric Cancer Therapy Market Research Report 2025

Code: QYRE-Auto-7M13854
Report
January 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Glaxo SmithKline plc
Roche Holding Limited
AptarGroup Incorporated
Squibb Company
Boston Scientific Corporation
Pfizer Inc
Agilent Technologies Inc
Illumina Inc
Thermo Fisher Scientific Inc
General Electric Company
BD
Abbott
Merck
F Hoffmann La Roche Ltd

Gastric Cancer Therapy Market Size

The global market for Gastric Cancer Therapy was valued at US$ 903 million in the year 2024 and is projected to reach a revised size of US$ 1282 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Gastric Cancer Therapy Market

Gastric Cancer Therapy Market

Gastric Cancer Therapy is caused by uncontrolled abnormal cell proliferation that has the ability to spread and invade other sections of the body. Changes in the gene cause a single cell or a few cells to expand and replicate, which is when cancer begins. This could lead to the growth of a tumor, which is an abnormal mass of tissue. The creation of cancer cells in the stomach lining is known as Gastric Cancer Therapy or stomach cancer. Diet and stomach disorders are both risk factors for Gastric Cancer Therapy. Stomach pain, poor appetite, weight loss, indigestions, nausea, vomiting with or without blood are some of the symptoms of Gastric Cancer Therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastric Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Cancer Therapy.
The Gastric Cancer Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Cancer Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastric Cancer Therapy Market Report

Report Metric Details
Report Name Gastric Cancer Therapy Market
Accounted market size in year US$ 903 million
Forecasted market size in 2031 US$ 1282 million
CAGR 5.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Glaxo SmithKline Plc, Roche Holding Limited, AptarGroup Incorporated, Squibb Company, Boston Scientific Corporation, Pfizer., Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., General Electric Company, BD, Abbott, Merck, F. Hoffmann-La Roche Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastric Cancer Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastric Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gastric Cancer Therapy Market growing?

Ans: The Gastric Cancer Therapy Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Gastric Cancer Therapy Market size in 2031?

Ans: The Gastric Cancer Therapy Market size in 2031 will be US$ 1282 million.

Who are the main players in the Gastric Cancer Therapy Market report?

Ans: The main players in the Gastric Cancer Therapy Market are Novartis AG, Glaxo SmithKline Plc, Roche Holding Limited, AptarGroup Incorporated, Squibb Company, Boston Scientific Corporation, Pfizer., Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., General Electric Company, BD, Abbott, Merck, F. Hoffmann-La Roche Ltd.

What are the Application segmentation covered in the Gastric Cancer Therapy Market report?

Ans: The Applications covered in the Gastric Cancer Therapy Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Gastric Cancer Therapy Market report?

Ans: The Types covered in the Gastric Cancer Therapy Market report are Prescription Drugs, Non-Prescription Drugs

Recommended Reports

Stomach & Gastric Cancer

Cancer Therapy Drugs

Advanced Cancer Therapies

1 Gastric Cancer Therapy Market Overview
1.1 Product Definition
1.2 Gastric Cancer Therapy by Type
1.2.1 Global Gastric Cancer Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prescription Drugs
1.2.3 Non-Prescription Drugs
1.3 Gastric Cancer Therapy by Application
1.3.1 Global Gastric Cancer Therapy Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Gastric Cancer Therapy Market Size Estimates and Forecasts
1.4.1 Global Gastric Cancer Therapy Revenue 2020-2031
1.4.2 Global Gastric Cancer Therapy Sales 2020-2031
1.4.3 Global Gastric Cancer Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastric Cancer Therapy Market Competition by Manufacturers
2.1 Global Gastric Cancer Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastric Cancer Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastric Cancer Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastric Cancer Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastric Cancer Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastric Cancer Therapy, Product Type & Application
2.7 Global Key Manufacturers of Gastric Cancer Therapy, Date of Enter into This Industry
2.8 Global Gastric Cancer Therapy Market Competitive Situation and Trends
2.8.1 Global Gastric Cancer Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastric Cancer Therapy Players Market Share by Revenue
2.8.3 Global Gastric Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastric Cancer Therapy Market Scenario by Region
3.1 Global Gastric Cancer Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastric Cancer Therapy Sales by Region: 2020-2031
3.2.1 Global Gastric Cancer Therapy Sales by Region: 2020-2025
3.2.2 Global Gastric Cancer Therapy Sales by Region: 2026-2031
3.3 Global Gastric Cancer Therapy Revenue by Region: 2020-2031
3.3.1 Global Gastric Cancer Therapy Revenue by Region: 2020-2025
3.3.2 Global Gastric Cancer Therapy Revenue by Region: 2026-2031
3.4 North America Gastric Cancer Therapy Market Facts & Figures by Country
3.4.1 North America Gastric Cancer Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastric Cancer Therapy Sales by Country (2020-2031)
3.4.3 North America Gastric Cancer Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gastric Cancer Therapy Market Facts & Figures by Country
3.5.1 Europe Gastric Cancer Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastric Cancer Therapy Sales by Country (2020-2031)
3.5.3 Europe Gastric Cancer Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastric Cancer Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Gastric Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastric Cancer Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastric Cancer Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastric Cancer Therapy Market Facts & Figures by Country
3.7.1 Latin America Gastric Cancer Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastric Cancer Therapy Sales by Country (2020-2031)
3.7.3 Latin America Gastric Cancer Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastric Cancer Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastric Cancer Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastric Cancer Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastric Cancer Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastric Cancer Therapy Sales by Type (2020-2031)
4.1.1 Global Gastric Cancer Therapy Sales by Type (2020-2025)
4.1.2 Global Gastric Cancer Therapy Sales by Type (2026-2031)
4.1.3 Global Gastric Cancer Therapy Sales Market Share by Type (2020-2031)
4.2 Global Gastric Cancer Therapy Revenue by Type (2020-2031)
4.2.1 Global Gastric Cancer Therapy Revenue by Type (2020-2025)
4.2.2 Global Gastric Cancer Therapy Revenue by Type (2026-2031)
4.2.3 Global Gastric Cancer Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Gastric Cancer Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastric Cancer Therapy Sales by Application (2020-2031)
5.1.1 Global Gastric Cancer Therapy Sales by Application (2020-2025)
5.1.2 Global Gastric Cancer Therapy Sales by Application (2026-2031)
5.1.3 Global Gastric Cancer Therapy Sales Market Share by Application (2020-2031)
5.2 Global Gastric Cancer Therapy Revenue by Application (2020-2031)
5.2.1 Global Gastric Cancer Therapy Revenue by Application (2020-2025)
5.2.2 Global Gastric Cancer Therapy Revenue by Application (2026-2031)
5.2.3 Global Gastric Cancer Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Gastric Cancer Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Gastric Cancer Therapy Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Glaxo SmithKline Plc
6.2.1 Glaxo SmithKline Plc Company Information
6.2.2 Glaxo SmithKline Plc Description and Business Overview
6.2.3 Glaxo SmithKline Plc Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glaxo SmithKline Plc Gastric Cancer Therapy Product Portfolio
6.2.5 Glaxo SmithKline Plc Recent Developments/Updates
6.3 Roche Holding Limited
6.3.1 Roche Holding Limited Company Information
6.3.2 Roche Holding Limited Description and Business Overview
6.3.3 Roche Holding Limited Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Holding Limited Gastric Cancer Therapy Product Portfolio
6.3.5 Roche Holding Limited Recent Developments/Updates
6.4 AptarGroup Incorporated
6.4.1 AptarGroup Incorporated Company Information
6.4.2 AptarGroup Incorporated Description and Business Overview
6.4.3 AptarGroup Incorporated Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AptarGroup Incorporated Gastric Cancer Therapy Product Portfolio
6.4.5 AptarGroup Incorporated Recent Developments/Updates
6.5 Squibb Company
6.5.1 Squibb Company Company Information
6.5.2 Squibb Company Description and Business Overview
6.5.3 Squibb Company Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Squibb Company Gastric Cancer Therapy Product Portfolio
6.5.5 Squibb Company Recent Developments/Updates
6.6 Boston Scientific Corporation
6.6.1 Boston Scientific Corporation Company Information
6.6.2 Boston Scientific Corporation Description and Business Overview
6.6.3 Boston Scientific Corporation Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boston Scientific Corporation Gastric Cancer Therapy Product Portfolio
6.6.5 Boston Scientific Corporation Recent Developments/Updates
6.7 Pfizer.
6.7.1 Pfizer. Company Information
6.7.2 Pfizer. Description and Business Overview
6.7.3 Pfizer. Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer. Gastric Cancer Therapy Product Portfolio
6.7.5 Pfizer. Recent Developments/Updates
6.8 Agilent Technologies, Inc.
6.8.1 Agilent Technologies, Inc. Company Information
6.8.2 Agilent Technologies, Inc. Description and Business Overview
6.8.3 Agilent Technologies, Inc. Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Agilent Technologies, Inc. Gastric Cancer Therapy Product Portfolio
6.8.5 Agilent Technologies, Inc. Recent Developments/Updates
6.9 Illumina, Inc.
6.9.1 Illumina, Inc. Company Information
6.9.2 Illumina, Inc. Description and Business Overview
6.9.3 Illumina, Inc. Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Illumina, Inc. Gastric Cancer Therapy Product Portfolio
6.9.5 Illumina, Inc. Recent Developments/Updates
6.10 Thermo Fisher Scientific, Inc.
6.10.1 Thermo Fisher Scientific, Inc. Company Information
6.10.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.10.3 Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Product Portfolio
6.10.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.11 General Electric Company
6.11.1 General Electric Company Company Information
6.11.2 General Electric Company Description and Business Overview
6.11.3 General Electric Company Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.11.4 General Electric Company Gastric Cancer Therapy Product Portfolio
6.11.5 General Electric Company Recent Developments/Updates
6.12 BD
6.12.1 BD Company Information
6.12.2 BD Description and Business Overview
6.12.3 BD Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BD Gastric Cancer Therapy Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 Abbott
6.13.1 Abbott Company Information
6.13.2 Abbott Description and Business Overview
6.13.3 Abbott Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abbott Gastric Cancer Therapy Product Portfolio
6.13.5 Abbott Recent Developments/Updates
6.14 Merck
6.14.1 Merck Company Information
6.14.2 Merck Description and Business Overview
6.14.3 Merck Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Merck Gastric Cancer Therapy Product Portfolio
6.14.5 Merck Recent Developments/Updates
6.15 F. Hoffmann-La Roche Ltd.
6.15.1 F. Hoffmann-La Roche Ltd. Company Information
6.15.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.15.3 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales, Revenue and Gross Margin (2020-2025)
6.15.4 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product Portfolio
6.15.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastric Cancer Therapy Industry Chain Analysis
7.2 Gastric Cancer Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastric Cancer Therapy Production Mode & Process Analysis
7.4 Gastric Cancer Therapy Sales and Marketing
7.4.1 Gastric Cancer Therapy Sales Channels
7.4.2 Gastric Cancer Therapy Distributors
7.5 Gastric Cancer Therapy Customer Analysis
8 Gastric Cancer Therapy Market Dynamics
8.1 Gastric Cancer Therapy Industry Trends
8.2 Gastric Cancer Therapy Market Drivers
8.3 Gastric Cancer Therapy Market Challenges
8.4 Gastric Cancer Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Glaxo SmithKline plc
Roche Holding Limited
AptarGroup Incorporated
Squibb Company
Boston Scientific Corporation
Pfizer Inc
Agilent Technologies Inc
Illumina Inc
Thermo Fisher Scientific Inc
General Electric Company
BD
Abbott
Merck
F Hoffmann La Roche Ltd
List of Tables
 Table 1. Global Gastric Cancer Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastric Cancer Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastric Cancer Therapy Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastric Cancer Therapy Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gastric Cancer Therapy Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastric Cancer Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastric Cancer Therapy Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastric Cancer Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastric Cancer Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastric Cancer Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastric Cancer Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of Gastric Cancer Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastric Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Cancer Therapy as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastric Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastric Cancer Therapy Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gastric Cancer Therapy Sales Market Share by Region (2020-2025)
 Table 19. Global Gastric Cancer Therapy Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gastric Cancer Therapy Sales Market Share by Region (2026-2031)
 Table 21. Global Gastric Cancer Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastric Cancer Therapy Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastric Cancer Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastric Cancer Therapy Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastric Cancer Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastric Cancer Therapy Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gastric Cancer Therapy Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gastric Cancer Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastric Cancer Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastric Cancer Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastric Cancer Therapy Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gastric Cancer Therapy Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gastric Cancer Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastric Cancer Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastric Cancer Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastric Cancer Therapy Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gastric Cancer Therapy Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gastric Cancer Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastric Cancer Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastric Cancer Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastric Cancer Therapy Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gastric Cancer Therapy Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gastric Cancer Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastric Cancer Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastric Cancer Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastric Cancer Therapy Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gastric Cancer Therapy Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gastric Cancer Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastric Cancer Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastric Cancer Therapy Sales (K Units) by Type (2020-2025)
 Table 51. Global Gastric Cancer Therapy Sales (K Units) by Type (2026-2031)
 Table 52. Global Gastric Cancer Therapy Sales Market Share by Type (2020-2025)
 Table 53. Global Gastric Cancer Therapy Sales Market Share by Type (2026-2031)
 Table 54. Global Gastric Cancer Therapy Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastric Cancer Therapy Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastric Cancer Therapy Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastric Cancer Therapy Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastric Cancer Therapy Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gastric Cancer Therapy Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gastric Cancer Therapy Sales (K Units) by Application (2020-2025)
 Table 61. Global Gastric Cancer Therapy Sales (K Units) by Application (2026-2031)
 Table 62. Global Gastric Cancer Therapy Sales Market Share by Application (2020-2025)
 Table 63. Global Gastric Cancer Therapy Sales Market Share by Application (2026-2031)
 Table 64. Global Gastric Cancer Therapy Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastric Cancer Therapy Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastric Cancer Therapy Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastric Cancer Therapy Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastric Cancer Therapy Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gastric Cancer Therapy Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis AG Gastric Cancer Therapy Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Glaxo SmithKline Plc Company Information
 Table 76. Glaxo SmithKline Plc Description and Business Overview
 Table 77. Glaxo SmithKline Plc Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Glaxo SmithKline Plc Gastric Cancer Therapy Product
 Table 79. Glaxo SmithKline Plc Recent Developments/Updates
 Table 80. Roche Holding Limited Company Information
 Table 81. Roche Holding Limited Description and Business Overview
 Table 82. Roche Holding Limited Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Holding Limited Gastric Cancer Therapy Product
 Table 84. Roche Holding Limited Recent Developments/Updates
 Table 85. AptarGroup Incorporated Company Information
 Table 86. AptarGroup Incorporated Description and Business Overview
 Table 87. AptarGroup Incorporated Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. AptarGroup Incorporated Gastric Cancer Therapy Product
 Table 89. AptarGroup Incorporated Recent Developments/Updates
 Table 90. Squibb Company Company Information
 Table 91. Squibb Company Description and Business Overview
 Table 92. Squibb Company Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Squibb Company Gastric Cancer Therapy Product
 Table 94. Squibb Company Recent Developments/Updates
 Table 95. Boston Scientific Corporation Company Information
 Table 96. Boston Scientific Corporation Description and Business Overview
 Table 97. Boston Scientific Corporation Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boston Scientific Corporation Gastric Cancer Therapy Product
 Table 99. Boston Scientific Corporation Recent Developments/Updates
 Table 100. Pfizer. Company Information
 Table 101. Pfizer. Description and Business Overview
 Table 102. Pfizer. Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer. Gastric Cancer Therapy Product
 Table 104. Pfizer. Recent Developments/Updates
 Table 105. Agilent Technologies, Inc. Company Information
 Table 106. Agilent Technologies, Inc. Description and Business Overview
 Table 107. Agilent Technologies, Inc. Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Agilent Technologies, Inc. Gastric Cancer Therapy Product
 Table 109. Agilent Technologies, Inc. Recent Developments/Updates
 Table 110. Illumina, Inc. Company Information
 Table 111. Illumina, Inc. Description and Business Overview
 Table 112. Illumina, Inc. Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Illumina, Inc. Gastric Cancer Therapy Product
 Table 114. Illumina, Inc. Recent Developments/Updates
 Table 115. Thermo Fisher Scientific, Inc. Company Information
 Table 116. Thermo Fisher Scientific, Inc. Description and Business Overview
 Table 117. Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Product
 Table 119. Thermo Fisher Scientific, Inc. Recent Developments/Updates
 Table 120. General Electric Company Company Information
 Table 121. General Electric Company Description and Business Overview
 Table 122. General Electric Company Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. General Electric Company Gastric Cancer Therapy Product
 Table 124. General Electric Company Recent Developments/Updates
 Table 125. BD Company Information
 Table 126. BD Description and Business Overview
 Table 127. BD Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. BD Gastric Cancer Therapy Product
 Table 129. BD Recent Developments/Updates
 Table 130. Abbott Company Information
 Table 131. Abbott Description and Business Overview
 Table 132. Abbott Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Abbott Gastric Cancer Therapy Product
 Table 134. Abbott Recent Developments/Updates
 Table 135. Merck Company Information
 Table 136. Merck Description and Business Overview
 Table 137. Merck Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Merck Gastric Cancer Therapy Product
 Table 139. Merck Recent Developments/Updates
 Table 140. F. Hoffmann-La Roche Ltd. Company Information
 Table 141. F. Hoffmann-La Roche Ltd. Description and Business Overview
 Table 142. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product
 Table 144. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Gastric Cancer Therapy Distributors List
 Table 148. Gastric Cancer Therapy Customers List
 Table 149. Gastric Cancer Therapy Market Trends
 Table 150. Gastric Cancer Therapy Market Drivers
 Table 151. Gastric Cancer Therapy Market Challenges
 Table 152. Gastric Cancer Therapy Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastric Cancer Therapy
 Figure 2. Global Gastric Cancer Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastric Cancer Therapy Market Share by Type: 2024 & 2031
 Figure 4. Prescription Drugs Product Picture
 Figure 5. Non-Prescription Drugs Product Picture
 Figure 6. Global Gastric Cancer Therapy Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gastric Cancer Therapy Market Share by Application: 2024 & 2031
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Gastric Cancer Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Gastric Cancer Therapy Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Gastric Cancer Therapy Sales (2020-2031) & (K Units)
 Figure 13. Global Gastric Cancer Therapy Average Price (US$/Unit) & (2020-2031)
 Figure 14. Gastric Cancer Therapy Report Years Considered
 Figure 15. Gastric Cancer Therapy Sales Share by Manufacturers in 2024
 Figure 16. Global Gastric Cancer Therapy Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Gastric Cancer Therapy Players: Market Share by Revenue in Gastric Cancer Therapy in 2024
 Figure 18. Gastric Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Gastric Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Gastric Cancer Therapy Sales Market Share by Country (2020-2031)
 Figure 21. North America Gastric Cancer Therapy Revenue Market Share by Country (2020-2031)
 Figure 22. United States Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Gastric Cancer Therapy Sales Market Share by Country (2020-2031)
 Figure 25. Europe Gastric Cancer Therapy Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Gastric Cancer Therapy Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Gastric Cancer Therapy Revenue Market Share by Region (2020-2031)
 Figure 33. China Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Gastric Cancer Therapy Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Gastric Cancer Therapy Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Gastric Cancer Therapy Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Gastric Cancer Therapy Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Gastric Cancer Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Gastric Cancer Therapy by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Gastric Cancer Therapy by Type (2020-2031)
 Figure 54. Global Gastric Cancer Therapy Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Gastric Cancer Therapy by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Gastric Cancer Therapy by Application (2020-2031)
 Figure 57. Global Gastric Cancer Therapy Price (US$/Unit) by Application (2020-2031)
 Figure 58. Gastric Cancer Therapy Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Gastrointestinal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastric Cancer Drugs Market Research Report 2024
Global Stomach Cancer Drugs Market Insights Forecast to 2030
Helicobacter Pylori Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastric Treatment Equipment Market Research Report 2024
Global Stomach Medicine Market Research Report 2024
Global Pancreatic Cancer Therapy Market Research Report 2024
Global Pancreatic Cancer Therapeutics Market Research Report 2024
Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Gastritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stomach Cancer and Gastric Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Cancer Devices Market Research Report 2024
Acute Gastritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stomach Cancer and Gastric Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapy For Cancer Market Research Report 2024
Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibody for Gastric Cancer Market Research Report 2024
Gastric Stimulation System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions